Aurobindo Pharma’s Subsidiary Receives WHO GMP Approval; Share Prices Remain Stable
On March 12, Aurobindo Pharma’s share price remained largely unchanged after the company’s subsidiary received approval from the World Health Organization (WHO) for Good Manufacturing Practices (GMP). As of 09:56 am, Aurobindo Pharma was trading at Rs 1,063.90 on the BSE, down Rs 0.45 or 0.04 percent. The WHO’s Prequalification Unit Inspection Team (PQT-INS) inspected … Read more